Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1994 Dec;70(830):860–862. doi: 10.1136/pgmj.70.830.860

Thalidomide--the way forward.

J M Gardner-Medwin 1, R J Powell 1
PMCID: PMC2398026  PMID: 7870630

Full text

PDF
861

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURLEY D. M., DENNISON T. C., HARRISON W. Clinical experience with a new sedative drug. Practitioner. 1959 Jul;183:57–61. [PubMed] [Google Scholar]
  2. Bahmer F. A., Zaun H., Luszpinski P. Thalidomide treatment of recurrent erythema multiforme. Acta Derm Venereol. 1982;62(5):449–450. [PubMed] [Google Scholar]
  3. Barnhill R. L., McDougall A. C. Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J Am Acad Dermatol. 1982 Sep;7(3):317–323. doi: 10.1016/s0190-9622(82)70118-5. [DOI] [PubMed] [Google Scholar]
  4. Bowers P. W., Powell R. J. Effect of thalidomide on orogenital ulceration. Br Med J (Clin Res Ed) 1983 Sep 17;287(6395):799–800. doi: 10.1136/bmj.287.6395.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eravelly J., Waters M. F. Thalidomide in Weber-Christian disease. Lancet. 1977 Jan 29;1(8005):251–251. doi: 10.1016/s0140-6736(77)91039-x. [DOI] [PubMed] [Google Scholar]
  6. FULLERTON P. M., KREMER M. Neuropathy after intake of thalidomide (distaval). Br Med J. 1961 Sep 30;2(5256):855–858. doi: 10.1136/bmj.2.5256.855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hawkins D. F. Thalidomide for systemic lupus erythematosus. Lancet. 1992 Apr 25;339(8800):1057–1057. doi: 10.1016/0140-6736(92)90580-v. [DOI] [PubMed] [Google Scholar]
  8. Heney D., Lewis I. J., Bailey C. C. Thalidomide for chronic graft-versus-host disease in children. Lancet. 1988 Dec 3;2(8623):1317–1317. doi: 10.1016/s0140-6736(88)92931-5. [DOI] [PubMed] [Google Scholar]
  9. Heney D., Norfolk D. R., Wheeldon J., Bailey C. C., Lewis I. J., Barnard D. L. Thalidomide treatment for chronic graft-versus-host disease. Br J Haematol. 1991 May;78(1):23–27. doi: 10.1111/j.1365-2141.1991.tb04377.x. [DOI] [PubMed] [Google Scholar]
  10. KELLER H., KUNZ W., MUCKTER H. N-Phthalyl-glutaminsäure-imid; experimentelle Untersuchungen an einem neuen synthetischen Produkt mit sedativen Eigenschaften. Arzneimittelforschung. 1956 Aug;6(8):426–430. [PubMed] [Google Scholar]
  11. LENZ W., KNAPP K. [Thalidomide embryopathy]. Dtsch Med Wochenschr. 1962 Jun 15;87:1232–1242. doi: 10.1055/s-0028-1111892. [DOI] [PubMed] [Google Scholar]
  12. Larsson H. Treatment of severe colitis in Behçet's syndrome with thalidomide (CG-217). J Intern Med. 1990 Oct;228(4):405–407. doi: 10.1111/j.1365-2796.1990.tb00253.x. [DOI] [PubMed] [Google Scholar]
  13. Londoño F. Thalidomide in the treatment of actinic prurigo. Int J Dermatol. 1973 Sep-Oct;12(5):326–328. doi: 10.1111/j.1365-4362.1973.tb00066.x. [DOI] [PubMed] [Google Scholar]
  14. MELLIN G. W., KATZENSTEIN M. The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies. N Engl J Med. 1962 Dec 13;267:1238–concl. doi: 10.1056/NEJM196212132672407. [DOI] [PubMed] [Google Scholar]
  15. Makonkawkeyoon S., Limson-Pobre R. N., Moreira A. L., Schauf V., Kaplan G. Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5974–5978. doi: 10.1073/pnas.90.13.5974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Marwick C. More cautionary labeling appears on isotretinoin. JAMA. 1984 Jun 22;251(24):3208–3209. [PubMed] [Google Scholar]
  17. Mascaro J. M., Lecha M., Torras H. Thalidomide in the treatment of recurrent, necrotic, and giant mucocutaneous aphthae and aphthosis. Arch Dermatol. 1979 May;115(5):636–637. [PubMed] [Google Scholar]
  18. McCarthy D. M., Kanfer E., Taylor J., Barrett A. J. Thalidomide for graft-versus-host disease. Lancet. 1988 Nov 12;2(8620):1135–1135. doi: 10.1016/s0140-6736(88)90546-6. [DOI] [PubMed] [Google Scholar]
  21. Powell R. J., Allen B. R., Jenkins J. S., Steele L., Hunneyball I., Maurice P. D., Littlewood S. M. Investigation and treatment of orogenital ulceration; studies on a possible mode of action of thalidomide. Br J Dermatol. 1985 Jul;113 (Suppl 28):141–144. doi: 10.1111/j.1365-2133.1985.tb15645.x. [DOI] [PubMed] [Google Scholar]
  22. Ryan J., Colman J., Pedersen J. Thalidomide to treat esophageal ulcer in AIDS. N Engl J Med. 1992 Jul 16;327(3):208–209. doi: 10.1056/NEJM199207163270319. [DOI] [PubMed] [Google Scholar]
  23. SHESKIN J. THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS. Clin Pharmacol Ther. 1965 May-Jun;6:303–306. doi: 10.1002/cpt196563303. [DOI] [PubMed] [Google Scholar]
  24. Samsoen M., Grosshans E., Basset A. La thalidomide dans le traitement du lupus érythémateux chronoque (L.E.C.). Ann Dermatol Venereol. 1980 Jun;107(6):515–523. [PubMed] [Google Scholar]
  25. Saylan T., Saltik I. Thalidomide in the treatment of Behçet's syndrome. Arch Dermatol. 1982 Aug;118(8):536–536. [PubMed] [Google Scholar]
  26. Sheskin J. Further observation with thalidomide in lepra reactions. Lepr Rev. 1965 Oct;36(4):183–187. doi: 10.5935/0305-7518.19650036. [DOI] [PubMed] [Google Scholar]
  27. Strazzi S., Lebbe C., Geoffray C., Ablon G., Morel P., Verola O., Molina J. M. Aphthous ulcers in HIV-infected patients: treatment with thalidomide. Genitourin Med. 1992 Dec;68(6):424–425. doi: 10.1136/sti.68.6.424-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tamura F., Vogelsang G. B., Reitz B. A., Baumgartner W. A., Herskowitz A. Combination thalidomide and cyclosporine for cardiac allograft rejection. Comparison with combination methylprednisolone and cyclosporine. Transplantation. 1990 Jan;49(1):20–25. doi: 10.1097/00007890-199001000-00005. [DOI] [PubMed] [Google Scholar]
  29. Venencie P. Y., Saurat J. H. Pyoderma gangrenosum chez un enfant. Traitement par la thalidomide. Ann Pediatr (Paris) 1982 Jan;29(1):67–69. [PubMed] [Google Scholar]
  30. Vogelsang G. B., Santos G. W., Colvin O. M., Chen T. Thalidomide for graft-versus-host disease. Lancet. 1988 Apr 9;1(8589):827–827. doi: 10.1016/s0140-6736(88)91690-x. [DOI] [PubMed] [Google Scholar]
  31. WEIDENBACH A. [Total phocomelia]. Zentralbl Gynakol. 1959 Dec 19;81:2048–2052. [PubMed] [Google Scholar]
  32. Waters M. F., Laing A. B., Ambikapathy A., Lennard-Jones J. E. Treatment of ulcerative colitis with thalidomide. Br Med J. 1979 Mar 24;1(6166):792–792. doi: 10.1136/bmj.1.6166.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Youle M., Clarbour J., Farthing C., Connolly M., Hawkins D., Staughton R., Gazzard B. Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody. BMJ. 1989 Feb 18;298(6671):432–432. doi: 10.1136/bmj.298.6671.432. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES